SK
Sanjay Kumar
About Sanjay Kumar
Data last updated:
Sanjay Kumar is a Director at Dolvis Bio Pharma Private Limited (since 2012), Director at Aingo Pharma Private Limited (since 2014) and Director at Dolphar Life Care Private Limited (since 2019), and holds 5 more current directorships. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹23.37 Cr; the largest is Dolvis Bio Pharma Private Limited at ₹12.57 Cr (FY 2024). Earlier, Sanjay Kumar was a Director at Jydem Bio Pharma Private Limited (2018–2020) and Director at Zither Pharmaceutical Private Limited (2009–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dolvis Bio Pharma Private Limited U24232CH2012PTC033674 | Director | 27 Mar 2012 | 2012 | ₹12.57 Cr (FY 2024) | Active |
 Aingo Pharma Private Limited U24232CH2013PTC034743 | Director | 18 Aug 2014 | 2013 | ₹6.77 Cr (FY 2024) | Active |
 Dolphar Life Care Private Limited U51909CH2018PTC042168 | Director | 09 Apr 2019 | 2018 | ₹2.46 Cr (FY 2024) | Active |
 Livewort Labs Private Limited U51909CH2019PTC042723 | Director | 07 Oct 2019 | 2019 | ₹1.58 Cr (FY 2024) | Active |
| Oasis Bio Bloom Llp ACF-1217 | Designated Partner | 24 Jan 2024 | 2024 | Active | |
| Meditech Bio Pharma Private Limited U51900CH2019PTC042730 | Director | 11 Oct 2019 | 2019 | Active | |
 Erika Remedies Private Limited U51909CH2018PTC042140 | Director | 09 Apr 2019 | 2018 | Active | |
| Vlead Labs Private Limited U51900CH2019PTC042411 | Director | 11 Mar 2019 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Jydem Bio Pharma Private Limited U74999CH2017PTC041797 | Director | 27 Oct 2018 | 2017 | ₹83.8 Lakh (FY 2024) | Active |
 Zither Pharmaceutical Private Limited U24100CH2009PTC031732 | Director | 14 Oct 2009 | 2009 | ₹6.64 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Piyush Garg | 10932953 | Dolvis Bio Pharma Private Limited | Director |
| Ram Gopal | 07033186 | Aingo Pharma Private Limited , Vlead Labs Private Limited | Director |
| Anita Garg | 08399386 | Dolphar Life Care Private Limited , Meditech Bio Pharma Private Limited | Director |
| Suresh Mittal | 01225927 | Livewort Labs Private Limited , Erika Remedies Private Limited and 1 more | Director |
| Aman Goyal | 06858178 | Oasis Bio Bloom Llp | Designated Partner |
| Girish Goyal | 10387490 | Oasis Bio Bloom Llp | Designated Partner |
| Vishav Bhushan Verma | 07980137 | Vlead Labs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Kumar
Sanjay Kumar currently holds 8 directorships: Dolvis Bio Pharma Private Limited (Director, since 27 Mar 2012, revenue ₹12.57 Cr (FY 2024)); Aingo Pharma Private Limited (Director, since 18 Aug 2014, revenue ₹6.77 Cr (FY 2024)); Dolphar Life Care Private Limited (Director, since 09 Apr 2019, revenue ₹2.46 Cr (FY 2024)); Livewort Labs Private Limited (Director, since 07 Oct 2019, revenue ₹1.58 Cr (FY 2024)); Oasis Bio Bloom Llp (Designated Partner, since 24 Jan 2024); and 3 more.
Sanjay Kumar was first appointed on 14 Oct 2009 as Director at Zither Pharmaceutical Private Limited. The most recent appointment on record is 24 Jan 2024 at Oasis Bio Bloom Llp.
The 4 current companies of Sanjay Kumar that report revenue have a combined latest revenue of ₹23.37 Cr: Dolvis Bio Pharma Private Limited ₹12.57 Cr (FY 2024); Aingo Pharma Private Limited ₹6.77 Cr (FY 2024); Dolphar Life Care Private Limited ₹2.46 Cr (FY 2024); Livewort Labs Private Limited ₹1.58 Cr (FY 2024).
Sanjay Kumar held 2 earlier board appointments: Jydem Bio Pharma Private Limited (Director, 27 Oct 2018 to 02 Nov 2020); Zither Pharmaceutical Private Limited (Director, 14 Oct 2009 to 08 Nov 2017).
The current boards of Sanjay Kumar's companies include Piyush Garg (Dolvis Bio Pharma Private Limited), Ram Gopal (Aingo Pharma Private Limited), Anita Garg (Dolphar Life Care Private Limited), Suresh Mittal (Livewort Labs Private Limited), Aman Goyal (Oasis Bio Bloom Llp), Girish Goyal (Oasis Bio Bloom Llp), among others.